Multidisciplinary Care for Mesothelioma

multidisciplinary care for mesothelioma

Italian doctors say patients are more likely to enter clinical trials when they have multidisciplinary care for mesothelioma.  Inclusion in clinical trials is one of the best ways for mesothelioma patients to access cutting edge treatments.  The study shows multidisciplinary care for mesothelioma helps funnel patients into trials. It  also provides better monitoring of treatment response and better access to palliative care.  What is the Multidisciplinary Approach? In most hospitals, mesothelioma patients receive diagnosis from a cancer doctor or oncologist. The oncologist orders the appropriate diagnostic tests and helps craft the treatment plan. Diagnostic imaging or radiotherapy for mesothelioma is usually overseen by radiology specialists. But multidisciplinary care for mesothelioma involves a bigger team of people. The team consists of … Continue reading Multidisciplinary Care for Mesothelioma »

Mesothelioma Recurrence After PD Surgery

mesothelioma recurrence after PD surgery

A new study finds that mesothelioma recurrence after PD surgery is common but most patients still live for more than a year afterwards. More than a third were still alive three years after recurrence. The study included 90 Japanese patients with malignant pleural mesothelioma.  Those who lived for at least a year without mesothelioma recurrence after PD surgery had the best chance of longer term survival. A good performance status and undergoing additional treatment were also key to better outcomes.  Understanding Pleurectomy with Decortication (PD) Surgery Pleural mesothelioma is a virulent cancer that occurs on the membrane around the lungs. There is no cure for mesothelioma. Even with the best treatment, the cancer usually comes back. The goal of most … Continue reading Mesothelioma Recurrence After PD Surgery »

Tumor Treating Fields for Mesothelioma Faces Criticism

tumor treating fields

Tumor Treating Fields for mesothelioma is coming under fire from some other researchers. The treatment uses electricity to interfere with division of cancer cells. The FDA approved it for mesothelioma last year under the Humanitarian Device Exemption. It is only the second treatment ever approved for asbestos cancer.  But scientists in Italy and the Netherlands are disputing some of the findings from the STELLAR trial of TTFields. They published separate articles in a recent issue of The Lancet Oncology. STELLAR tested Tumor Treating Fields along with chemotherapy as a novel mesothelioma treatment. The FDA based its approval on the STELLAR results.  But the newly published articles suggest that there were problems with the trial. Both say Tumor Treating Fields is … Continue reading Tumor Treating Fields for Mesothelioma Faces Criticism »

Study Supports Curative Radiation Therapy for Pleural Mesothelioma

radiation therapy for pleural mesothelioma

A new study out of Turkey supports the idea of using highly targeted radiation therapy for pleural mesothelioma that can’t be treated surgically. Pleural mesothelioma is a cancer that grows on the membrane around the lungs. The membrane is called the pleura. Like all forms of mesothelioma, it carries a grim prognosis. But the Turkish researchers say new radiotherapy techniques offer the promise of better outcomes. They compared two types of radiation therapy for pleural mesothelioma. They found that both could be delivered safely and with limited damage to nearby organs.  Unrectable Pleural Mesothelioma The first-line treatment for pleural mesothelioma is chemotherapy. Ideally, chemotherapy will help to shrink the pleural mesothelioma. Then doctors can remove most of it surgically. They … Continue reading Study Supports Curative Radiation Therapy for Pleural Mesothelioma »

Sarcomatoid Mesothelioma Treatment Focuses on Two-Drug Combo

sarcomatoid mesothelioma treatment

Researchers in Spain are developing what they hope will be a more effective sarcomatoid mesothelioma treatment. The new treatment focuses on a pair of drugs that are already being tested in humans.  Mesothelioma impacts about 2,500 Americans each year. Sarcomatoid mesothelioma is a rare form of this rare cancer. About a quarter of the annual cases are sarcomatoid.  This form of cancer is even more aggressive than epithelioid mesothelioma. But sarcomatoid mesothelioma treatment is not significantly different. Neither are the results.  But the new study could change the prognosis for people with asbestos cancer. It appears in the journal Cancer Research. Chemotherapy is the Primary Sarcomatoid Mesothelioma Treatment Most people with malignant mesothelioma receive chemotherapy with cisplatin and Alimta. This … Continue reading Sarcomatoid Mesothelioma Treatment Focuses on Two-Drug Combo »

Mesothelioma and Tile Production Linked by New Case Studies

mesothelioma and tile production

Two newly published case studies have drawn a link between malignant mesothelioma and tile production.  The authors of the new report analyzed the cases of two people who contracted mesothelioma after working for a tile manufacturer.  Both people were exposed to talc in their work. This is likely where they encountered the asbestos that may have triggered mesothelioma. Understanding the Different Types of Tile Malignant mesothelioma is caused by exposure to asbestos. Before the 1990s, many homes and businesses were built with asphalt or vinyl ‘tiles’ made with asbestos. These types of tiles are still in many older buildings. Disturbing or removing them can pose a risk for mesothelioma.  But the current report focuses on ceramic tile workers. Mesothelioma and … Continue reading Mesothelioma and Tile Production Linked by New Case Studies »

Mesothelioma in Seafarers: Cancer Risk at Sea

mesothelioma in seafarers

New research has revealed a higher risk for mesothelioma in seafarers and fisherman in Nordic countries. A seafarer is someone who makes their living at sea. The study conducted by the Danish Cancer Society found an elevated risk in most types of cancer among Nordic seafarers. Mesothelioma was one of just three cancers whose cause was not difficult to guess. The research included tens of thousands of seamen and fisherman and spanned more than 40 years. The authors say malignant mesothelioma in seafarers is the result of on-the-job asbestos exposure. Asbestos at Sea Asbestos is a toxic mineral. It causes malignant mesothelioma and several other types of cancer. Before scientists made the connection between asbestos and cancer, it was a … Continue reading Mesothelioma in Seafarers: Cancer Risk at Sea »

Asbestos and Lung Cancer: Study Highlights the Link

asbestos and lung cancer

A new report on asbestos and lung cancer says asbestos could be to blame for the cancer, even if the patient is a heavy smoker.  In smokers, lung cancer is usually attributed to tobacco use. But cancer researchers in Australia and Finland say that is not always right, especially if the patient has been exposed to asbestos. They propose new criteria for establishing the cause of lung cancer in asbestos-exposed people. The criteria would apply to both smokers and non-smokers. Mesothelioma is Not the Only Cancer Linked to Exposure Malignant mesothelioma is the cancer most often associated with asbestos exposure.  Mesothelioma is a rare but fast-growing and treatment-resistant cancer. Asbestos exposure is the only known cause of mesothelioma. Smoking increases … Continue reading Asbestos and Lung Cancer: Study Highlights the Link »

Drug May help Mesothelioma Patients Overcome Resistance to Chemotherapy

resistance to chemotherapy

A newly-identified compound might eventually help mesothelioma patients overcome resistance to chemotherapy.  Chemotherapy resistance is one of the main reasons that mesothelioma treatments fail.  But researchers at Duke University and the Massachusetts Institute of Technology have identified a compound that combats resistance to chemotherapy with cisplatin.  Cisplatin is one of the primary drugs in first-line chemotherapy for mesothelioma. If mesothelioma cells can be sensitized to it, patients may have better outcomes.   First-Line Treatment for Malignant Mesothelioma Pleural mesothelioma is a cancer that grows on the lining around the lungs. Peritoneal mesothelioma starts on the lining of the abdomen. Both types of mesothelioma are caused by asbestos exposure.  Chemotherapy with cisplatin and pemetrexed (Alimta) is the treatment that doctors usually try … Continue reading Drug May help Mesothelioma Patients Overcome Resistance to Chemotherapy »

Uncertainly, Worry, and Hope Characterize the Experience of Mesothelioma

experience of mesothelioma

The experience of mesothelioma is characterized by uncertainty and worry for some patients. But the same patients say they are also optimistic and hopeful.  These findings come from in-depth interviews with seven people with pleural mesothelioma. They were all patients at Penn-Presbyterian Medical Center in Philadelphia.  This is not the first study on the lived experience of mesothelioma. But the authors say American mesothelioma patients are underrepresented in the medical literature. The US has a higher number of mesothelioma deaths each year than any other country.  The new study shows the experience of these patients is much like that of mesothelioma patients elsewhere in the world.  Fostering Understanding, Identifying Needs Mesothelioma is an extremely rare cancer with a poor prognosis. … Continue reading Uncertainly, Worry, and Hope Characterize the Experience of Mesothelioma »

Get your free copy of
“Surviving Mesothelioma” Today!